Table 2.
Males | Females | |||||
---|---|---|---|---|---|---|
OR | CI | p | OR | CI | p | |
Race/ethnicity | ||||||
NH white | REF | — | — | REF | — | — |
NH African American | 0.96 | [0.43–2.14] | 0.92 | 0.74 | [0.44–1.24] | 0.25 |
Hispanic | 1.18 | [0.89–1.58] | 0.24 | 1.20 | [1.00–1.44] | 0.05 |
NH Asian/PI | 1.44 | [1.07–1.94] | 0.02 | 1.24 | [1.01–1.50] | 0.04 |
Other/unknown | 1.34 | [0.38–4.68] | 0.65 | 0.71 | [0.31–1.64] | 0.42 |
Age at diagnosis (years) | ||||||
15–34 | 0.93 | [0.65–1.33] | 0.69 | 1.50 | [1.17–1.92] | 0.001 |
35–44 | 0.82 | [0.58–1.16] | 0.26 | 1.26 | [0.99–1.61] | 0.06 |
45–54 | 1.16 | [0.86–1.58] | 0.33 | 0.88 | [0.68–1.14] | 0.33 |
≥55 | REF | — | — | REF | — | — |
Year of diagnosis | ||||||
1991–1993 | 0.34 | [0.16–0.73] | 0.006 | 0.68 | [0.41– 1.13] | 0.14 |
1994–1996 | 0.34 | [0.20–0.57] | <0.001 | 0.50 | [0.37–0.67] | <0.001 |
1997–1999 | 0.67 | [0.46–0.99] | 0.04 | 0.45 | [0.35–0.59] | <0.001 |
2000–2002 | 0.82 | [0.59–1.13] | 0.23 | 0.45 | [0.35–0.58] | <0.001 |
2003–2005 | 0.94 | [0.70–1.26] | 0.66 | 0.84 | [0.70–1.02] | 0.07 |
2006–2008 | REF | — | — | REF | — | — |
Histology | ||||||
Papillary | 1.82 | [1.12–2.98] | 0.02 | 1.59 | (1.10, 2.31) | 0.01 |
Follicular | REF | — | — | REF | — | — |
N stage | ||||||
N0 | REF | — | — | REF | — | — |
N1 | 2.86 | [2.22–3.69] | <0.001 | 3.61 | [3.05–4.26] | <0.001 |
Unknown | 1.83 | [1.20–2.79] | 0.005 | 2.01 | [1.51–2.67] | <0.001 |
M stage | ||||||
M0 | REF | — | — | REF | — | — |
M1 | 0.57 | [0.32–1.05] | 0.07 | 0.93 | [0.56—1.53] | 0.77 |
Unknown | 1.17 | [0.75–1.81] | 0.49 | 1.18 | [0.88–1.58] | 0.28 |
Tumor size | ||||||
<1 cm | REF | — | — | REF | — | — |
1–2 cm | 0.93 | [0.64–1.35] | 0.69 | 1.32 | [1.04–1.67] | 0.02 |
2–3 cm | 1.14 | [0.78–1.65] | 0.50 | 1.72 | [1.35–2.21] | <0.001 |
3–4 cm | 1.62 | [1.08–2.42] | 0.02 | 1.49 | [1.10–2.02] | 0.01 |
>4 cm | 2.05 | [1.43–2.96] | <0.001 | 2.19 | [1.64–2.93] | <0.001 |
Unknown | 1.25 | [0.75–2.10] | 0.39 | 1.96 | [1.40–2.75] | <0.001 |
Extrathyroidal extension | ||||||
No | REF | — | — | REF | — | — |
Yes | 2.19 | [1.73–2.78] | <0.001 | 2.34 | [1.99–2.74] | <0.001 |
Unknown | 1.69 | [0.88–3.24] | 0.11 | 1.28 | [0.79–2.09] | 0.31 |
Comorbidities at diagnosisa | ||||||
No admission ≤2 years after diagnosis | 1.28 | [0.89–1.83] | 0.18 | 1.38 | [1.12–1.70] | 0.002 |
0 | REF | — | — | REF | — | — |
1–2 | 1.37 | [0.92–2.04] | 0.12 | 1.37 | [1.07–1.75] | 0.01 |
≥3 | 0.99 | [0.56–1.77] | 0.98 | 1.38 | [0.92–2.06] | 0.12 |
Treatment | ||||||
No radioiodine | REF | — | — | REF | — | — |
Radioiodine | 1.66 | [1.29–2.14] | <0.001 | 1.62 | [1.37–1.92] | <0.001 |
Marital status | ||||||
Never married | 1.05 | [0.78–1.40] | 0.75 | 1.21 | [1.02–1.45] | 0.03 |
Previously married | 1.23 | [0.83–1.83] | 0.30 | 0.85 | [0.66–1.08] | 0.19 |
Married | REF | — | — | REF | — | — |
Unknown marital status | 1.22 | [0.49–3.05] | 0.67 | 1.46 | [0.86–2.46] | 0.16 |
Neighborhood socioeconomic status | ||||||
High | REF | — | — | REF | — | — |
Low | 0.94 | [0.74–1.18] | 0.59 | 0.84 | [0.72–0.98] | 0.03 |
Unknown | 2.01 | [0.99–4.06] | 0.05 | 0.50 | [0.20–1.25] | 0.14 |
Health insurance | ||||||
No insurance/self-pay | 0.40 | [0.12–1.33] | 0.14 | 1.36 | [0.86–2.14] | 0.19 |
Private insurance | REF | — | — | REF | — | — |
Medicaid/government | 0.87 | [0.54–1.41] | 0.58 | 0.69 | [0.52–0.93] | 0.01 |
Medicare | 1.83 | [1.32–2.53] | <0.001 | 1.29 | [0.97–1.72] | 0.08 |
Unknown | 0.97 | [0.53–1.77] | 0.92 | 0.46 | [0.30–0.71] | <0.001 |
Hospital thyroidectomy volumeb | ||||||
Low | REF | — | — | REF | — | — |
High | 1.07 | [0.85—1.35] | 0.54 | 0.85 | [0.73–0.99] | 0.04 |
Unknown | 0.61 | [0.40–0.93] | 0.02 | 0.84 | [0.65–1.07] | 0.15 |
Exlihauser comorbidity index diagnosis or two years prior to diagnosis, cancer was excluded as a comorbidity.
High-volume thyroidectomy hospital defined as the top 10% of hospitals performing thyroidectomies.
OR, odds ratio; CI, confidence interval; REF, reference group.